BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.
View all » Recent Releases
View all »Events & Presentations
Mar 31, 2015 at 8:30 AM ET
Q4 2014 Earnings Call